Wellgistics Health (MEDS) Stock Price, News & Analysis

Company Overview

Wellgistics Health, Inc. (NASDAQ: MEDS) is a healthcare technology and pharmaceutical services company focused on improving access to prescription medications. Through its platform and related services, the company connects pharmaceutical manufacturers, wholesalers, healthcare providers, pharmacies and patients within the prescription-drug supply chain.

The company provides technology and logistical solutions intended to support medication ordering, distribution and fulfillment. Its offerings are designed to help independent pharmacies and other healthcare participants manage prescription access, streamline supply-chain processes and serve patients more efficiently.

Wellgistics Health operates in the U.S. healthcare and pharmaceutical distribution market. The company’s business model combines software-enabled healthcare services with pharmaceutical supply-chain capabilities, although specific details about its geographic footprint, leadership and product portfolio may change as the company expands.

Key Stats

• Today's Range: $1.72 to $2.02
• 50-Day Range: $0.85 to $6.07
• 52-Week Range: $0.82 to $35.68
• Volume: 490,800 shs
• Average Volume: 4.15 million shs
• Market Capitalization: $5.86 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Wellgistics Health Stock Analysis - MarketRank™

Wellgistics Health scored higher than 24% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Wellgistics Health has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Wellgistics Health has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: N/A
• Proj. Earnings Growth: N/A

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

20.41% of the float of Wellgistics Health has been sold short.

Short Interest Ratio / Days to Cover

Wellgistics Health has a short interest ratio ("days to cover") of 0.07, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Wellgistics Health has recently decreased by 9.29%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Wellgistics Health does not currently pay a dividend.

Dividend Growth

Wellgistics Health does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: N/A

News Sentiment

Wellgistics Health has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.66 average news sentiment score of Healthcare companies.

Search Interest

Only 5 people have searched for MEDS on MarketBeat in the last 30 days. This is a decrease of -62% compared to the previous 30 days.

MarketBeat Follows

1 people have added Wellgistics Health to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Wellgistics Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

27.01% of the stock of Wellgistics Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

5.68% of the stock of Wellgistics Health is held by institutions.

Company Calendar

• Last Earnings: 8/17/2026
• Today: 11/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Distributors
• Current Symbol: NASDAQ:MEDS
• Previous Symbol: NASDAQ:WGRX
• CIK: 2030763
• Web: datamedsai.com
• Phone: 1-843-302-1785
• Fax: N/A
• Employees: 31
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($46.13)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$101.28 million
• Net Margins: -1,100.16%
• Pretax Margin: -1,100.17%
• Return on Equity: N/A
• Return on Assets: -171.81%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.14
• Quick Ratio: 0.10

Sales & Book Value

• Annual Sales: $23.34 million
• Price / Sales: 0.25
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($6.94) per share
• Price / Book: -0.26

Miscellaneous

• Outstanding Shares: 3,200,000
• Free Float: 2,334,000
• Market Cap: $5.86 million
• Optionable: N/A
• Beta: -3.51